All Things Insulin: Dosing, Monitoring, Titrating, and Transitioning

Description

New and emerging insulin products not only expand therapeutic options but also complicate treatment decisions for parents, prescribers, and pharmacists. Newer agents include insulin glargine U300, regular insulin U500, and insulin degludec U-100 and U-200. In this interactive case-based session, experts will facilitate a discussion about the safe and effective use of new insulin products including strategies to titrate insulin doses, methods to safely switch insulin products, and practical advice to minimize hypoglycemia.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

Compare the characteristics of new insulin agents available in the market.

Explain the potential roles of recently approved insulins in the management of type 1 and type 2 diabetes.